Latest Cancer: Kidney news
Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma
posted August 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASCO: Pembrolizumab Ups DFS in High-Risk Resected Clear-Cell RCC
posted June 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Occult Brain Mets Detected in Patients With Advanced Renal Cancer
posted May 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Nivolumab Plus Cabozantinib Tops Sunitinib for Renal Cell Carcinoma
posted March 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma 
Comparable Progression Risk Seen With Ablation Versus Surgery for T1a Renal Cell Carcinoma 
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries 
Global Burden of Renal Cancer Expected to Double by 2050 Monthly Specialist Briefings
Stay Connected
